down arrow

Bafna Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE878I01022
  • NSEID: BAFNAPH
  • BSEID: 532989
  • View on NSE | View on BSE
INR
154.80
7.35 (4.98%)
BSENSE

Jun 03, 03:30 PM

BSE+NSE Vol: 6.18 k

Access older stock analysis version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'19
Jun'19
Sep'18
Net Sales
11.57
6.85
8.84
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.57
6.85
8.84
Raw Material Cost
8.84
6.95
5.32
Purchase of Finished goods
0.00
0.00
0.16
(Increase) / Decrease In Stocks
0.02
-0.60
0.17
Employee Cost
2.43
2.31
2.18
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.65
1.06
0.83
Total Expenditure (Excl Depreciation)
11.94
9.71
8.66
Operating Profit (PBDIT) excl Other Income
-0.37
-2.86
0.18
Other Income
0.59
0.30
-0.03
Operating Profit (PBDIT)
0.22
-2.56
0.15
Interest
0.04
0.13
0.62
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
0.18
-2.69
-0.47
Depreciation
0.72
1.02
0.75
Profit Before Tax
-0.55
-3.71
-1.22
Tax
0.04
-1.58
0.05
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-0.59
-2.13
-1.28
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-0.59
-2.13
-1.28
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.59
-2.13
-1.28
Equity Capital
23.66
23.66
23.66
Face Value
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-0.25
-0.9
-0.54
Diluted Earnings per share
-0.25
-0.9
-0.8
Operating Profit Margin (Excl OI)
-3.2%
-41.75%
2.04%
Gross Profit Margin
1.56%
-39.27%
-5.32%
PAT Margin
-5.1%
-31.09%
-14.48%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 10.32% vs 7.95% in Dec 2025

stock-summary

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 49.46% vs -41.03% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 16.39% vs -28.74% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 19.77% vs 0.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Bafna Pharma. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
11.57
0
11.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.57
0
11.57
Raw Material Cost
8.84
0
8.84
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.02
0
0.02
Employee Cost
2.43
0
2.43
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
0.65
0.00
0.65
Total Expenditure (Excl Depreciation)
11.94
0
11.94
Operating Profit (PBDIT) excl Other Income
-0.37
0.00
-0.37
Other Income
0.59
0
0.59
Operating Profit (PBDIT)
0.22
0
0.22
Interest
0.04
0
0.04
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.18
0
0.18
Depreciation
0.72
0
0.72
Profit Before Tax
-0.55
0
-0.55
Tax
0.04
0
0.04
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-0.59
0
-0.59
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
-0.59
0
-0.59
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-0.59
0
-0.59
Equity Capital
23.66
0
23.66
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
-0.25
0
-0.25
Diluted Earnings per share
-0.25
0
-0.25
Operating Profit Margin (Excl OI)
-3.20%
0%
0.00
-3.20%
Gross Profit Margin
1.56%
0%
0.00
1.56%
PAT Margin
-5.10%
0%
0.00
-5.10%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 42.24 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 10.32% vs 7.95% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 8.14% vs -5.65% in Mar 2025

Quarterly - Standalone Net Profit
Standalone Net Profit 2.75 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 49.46% vs -41.03% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 109.92% vs -10.27% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.55 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 16.39% vs -28.74% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 13.78% vs 7.96% in Mar 2025

Quarterly - Interest
Interest 1.03 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 19.77% vs 0.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 25.61% vs 20.59% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.40%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."